News & Trends - MedTech & Diagnostics
Health insurers double their profits while elective surgery backlog becomes serious
MedTech News: A significant number of patients are waiting for elective surgery, 18 months after the first COVID-19 enforced shut down of procedures. It will be some time before the backlog can be addressed, said Australian Private Hospitals Association CEO Michael Roff.
“We estimated there were 340,000 episodes of care ‘missing’ from private hospitals in 2020. Taking into account the six months to the end of June, we now estimate that figure has fallen to 290,000, but it will still take a considerable amount of time to work through these cases.
“This is a serious situation for those affected patients and the healthcare system. These are surgeries and other treatments that have been deferred but they will need to be done at some stage and include procedures like total knee and hip replacements or cataract surgery that impact a patient’s ability to move around or to see,” he said.
The latest data released on 17 August by the Australian Prudential Regulation Authority (APRA) shows there were 978,797 episodes of care in private hospitals during the three months to the end of June. This is more than the previous quarter but will still not make up the gaps in health care need created by the various lockdowns around the country.
The APRA data also shows funds held over by private health insurers to fund elective surgery that could not take place during the pandemic – deferred claims liability – stands at $1.4 billion. Private health insurers have not made good on their promise to return these funds to members – only $400 million has been handed back in this quarter.
Medical Technology Association of Australia (MTAA) CEO, Ian Burgess, told Health Industry Hub “Corporate insurers profited from the pauses in elective surgery during the pandemic to the tune of $1.4 billion in deferred claims which they’ve continued to hoard rather than give back in full to consumers.
“MTAA is calling on the Government to investigate all regulatory and legislative options to ensure Corporate Insurer’s COVID-19 windfalls are returned to members and not used to increase million-dollar executive bonuses and investor pay-outs at the expense of consumers.”
Mr Roff added “This inaction on the part of insurers needs to be addressed. The Australian Competition and Consumer Commission has suggested these ‘deferred claims’ which have not been used to address the elective surgery backlog should be taken into consideration when the Health Minister considers premium increases.
“The APRA report indicates health insurers doubled their profit to $1.5 billion in the 12 months to the end of June. Therefore, the Minister should look very closely at any insurer trying to increase their premiums while still holding onto large amounts of their member’s money in the form of deferred claims.”
News & Trends - MedTech & Diagnostics
Government’s rejection of COVID Royal Commission a stark contrast to the UK and NZ
The Albanese government has dismissed the Senate legal and constitutional committee’s proposal for a COVID-19 pandemic royal commission with one […]
MoreNews & Trends - Biotechnology
AusBiotech and MTPConnect unite for landmark Summit on the nation’s biotech and medtech future
AusBiotech and MTPConnect have announced an ambitious new collaboration to host Australia’s first National Biotech and Medtech Development and Commercialisation […]
MoreNews & Trends - Pharmaceuticals
Targeted therapy with Astellas’ Xtandi improves prostate cancer outcomes for Aussie patients: New study
Pharma News: New research from the led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) […]
More